Table 3.
Neuroimaging characteristics of common disorders with de/dysmyelination
Confluency and area of predominance | ||
---|---|---|
Diffuse and symmetric | Area of predominance | Disorders |
Subcortical | Glutaric aciduria (Fig 1B) Canavan disease (Fig 1B) Urea cycle defects |
|
Frontal lobe | Alexander disease Metachromatic leukodystrophy (Fig 1B) Neuroaxonal leukodystrophy with axonal spheroids |
|
Periventricular | Metachromatic leukodystrophy (Fig 1B) Krabbe disease Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation Periventricular leukomalacia (Fig S1) |
|
Occipital | Krabbe disease (Fig 1B) X-linked adrenoleukodystrophy Peroxisomal disorders |
|
Diffuse cerebral | Vanishing white matter disease (Fig 1B) Megalencephalic leukoencephalopathy with subcortical cysts (Fig 1B) Merosin deficient congenital muscular dystrophy (Fig 1B) Mitochondrial disorders Most leukodystrophies at the advanced stages HIV encephalopathy (Fig S1) Toxic leukoencephalopathy (Fig S1) |
|
Cerebellar | Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation Leigh disease (Fig 1B) Alexander disease Maple syrup urine disease (Fig 1B) Adult onset autosomal dominant leukodystrophy |
|
Brainstem | Leigh disease (Fig 1B) Wilson disease Alexander disease Krabbe disease (Fig 1B) Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation |
|
Spinal Cord | Alexander disease Mitochondrial disorders (Fig 1B) Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation |
|
Focal and asymmetric | Genetic vasculopathies | Brain small vessel disease Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome Microangiopathy and leukoencephalopathy, pontine, autosomal dominant Aicardi-Goutières syndrome (Fig 1B) Cerebral amyloid angiopathy Leukoencephalopathy with calcifications and cysts Cerebral AD arteriopathy with subcortical infarcts and leukoencephalopathy Cerebral AR arteriopathy with subcortical infarcts and leukoencephalopathy (Fig 1B) RNASET2-related leukodystrophy NGLY1 related congenital disorder of deglycosylation Cathepsin A-related arteriopathy with strokes and leukodystrophy |
Acquired disorders with white matter abnormalities | Optic neuritis Transverse myelitis Acute disseminated encephalomyelitis (Fig S1) Multiple sclerosis (Fig S1) |
|
Special MRI characteristics | ||
Cystic changes | Megalencephalic leukoencephalopathy with subcortical cysts (Fig 1B) Mitochondrial disorders (Fig 1B) Vanishing white matter disease (Fig 1B) Glutaric aciduria (basal ganglia) |
|
Calcifications | Aicardi-Goutieres syndrome (Fig 1B) Galactosialidosis Brain small vessel disease with or without ocular anomalies Labrune's Syndrome or Leukoencephalopathy with Calcifications and Cysts Cerebro Retinal Microangiopathy with Calcifications and Cysts (Coats Plus Syndrome) Pseudo-TORCH syndrome 1 AARS2 related disease KARS2 related disease Adult onset leukoencephalopathy with axonal spheroids and pigmented glia COL4A1-related disorders Retinal vasculopathy with cerebral leukoencephalopathy Cerebral amyloid angiopathy Primary familial brain calcification Pseudohypoparathyroidism Leukoencephalopathy with calcifications and cysts |
|
Magnetic Resonance Spectroscopy | Elevated lactate | Mitochondrial disorders (Fig 1B) Some metabolic disorders (mild elevation) |
Altered metabolites | Ribose 5-phosphate isomerase deficiency (Elevated levels of arabitol and ribitol) Canavan disease (elevated N-acetylaspartic acid) (Fig 1B) |